effect overlay
activetrials
Stroke
Stroke
MIDAS2

Modafinil in Debilitating fatigue After Stroke 2(MIDAS2): A Phase ll, Multicentre, Prospective, Randomised, Placebo-controlled, Double-Blind, Parallel group with an adaptive sample size re-estimation study in Stroke Survivors
 

HREC: 2018.125
Principal Investigator: Prof Bruce Campbell
Coordinator contact: Amy McDonald
Funding: Non-Commercial
Stroke
Stroke
PRAISE

Post-Reperfusion Pathophysiology in Acute Ischemic Stroke
 

HREC: 2018.247
Principal Investigator: Dr Felix Ng
Coordinator contact: Dr Felix Ng
Funding: Non-Commercial
Stroke
Stroke
TOTO

Role of the geneTics in Post thrombolysis pAtients (RTPA); Targeting Optimal Thrombolysis Outcomes (TOTO)
 

HREC: 2018.312
Principal Investigator: Prof Bruce Campbell
Coordinator contact: Jessica Tsoleridis
Funding: Non-Commercial
Stroke
Stroke
MASTERS-2

MultiStem® Administration for Stroke Treatment and Enhanced Recovery Study (MASTERS-2)
 

HREC: 2019.094
Principal Investigator: Prof Bruce Campbell
Coordinator contact: David Jackson
Funding: Commercial
Stroke
Stroke
Eternal

Extending the time window for Tenecteplase by Effective Reperfusion of peNumbrAL tissue in patients with Large Vessel Occlusion
 

HREC: 2019.125
Principal Investigator: Prof Bruce Campbell
Coordinator contact:
Funding: Non-Commercial